1. Optogenetics: A new tool for cancer investigation and treatment

Siamak Alizadeh , Abolghasem Esmaeili, Jaleh Barar , Yadollah Omidi*

BioImpacts. 2022;12(4): 295-299. doi: 10.34172/bi.2021.22179

PMCID: PMC9376163 PMID: 35975208 Scopus ID: 85137389032

Article

PDF

Full Text

XML

Cited By:

Optogenetics approaches can provide us with outstanding tool to extend our understanding of how cells perceive, respond, and behave in meeting with complex signals, particularly in terms of cancer evasion from the anticancer immune system functions.

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons